Western blotting indicated that the expression of the COX-2 protein in the MCF-7 breast cancer cells of the COX-2-shRNA group was also significantly lower than that of the blank and mock groups (P<0.05), which was consistent with the results of the quantitative PCR (Fig. 2B). This evidence concerns the gene PTGS2 and breast cancer.